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Glutathione (GSH), γ-Glu-Cys-Gly, is one of the most abundant small non-protein thiol molecules in mammalian tissues, particu-
larly in the liver. Although glutathione is present in thiol-reduced (GSH) and disulfide oxidized (GSSG) forms, the predominant 
form is GSH and its content can exceed 10 mmol/L in liver cells. As an important intracellular reductant, GSH has many biologi-
cal functions in cells. Its major function is as an anti-oxidant as it can protect proteins from oxidation by reversible posttransla-
tional modification (glutathionylation) and decrease reactive oxygen species-mediated damage. However, it does have numerous 
other functions, including to chelate metal irons; enhance the absorption of iron, selenium and calcium; participate in lipid and 
insulin metabolism; regulate cellular events such as gene expression, DNA and protein synthesis, cell proliferation and apoptosis, 
redox-dependent signal transduction pathways, cytokine production and the immune response; and control protein glutathionyla-
tion. Therefore, GSH plays important roles in cell survival and health, and an imbalance in the GSH level can lead to many dis-
eases. In this review, we provide an overview of the function of GSH in mammalian cells and discuss future research of GSH.  
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Glutathione (GSH) is the most abundant intracellular non- 
protein thiol, and was first identified by Hopkins [1] and 
Kendall [2]. About 85%–90% GSH is freely distributed in 
the cytosol, but it is also present in organelles including the 
mitochondria, peroxisomes, nuclear matrix and endoplasmic 
reticulum (ER). It is mainly produced in cells to help protect 
against oxidative stress. It is well known that peroxides are 
highly unstable and readily form very damaging free radi-
cals upon decomposition, and these radical groups are the 
main source of oxidative stress. As an important reductant, 
GSH can scavenge these free radicals using the thiol bridge 
(i.e., via the sulfhydryl [–SH] groups), which generates wa-
ter and yields the oxidized form of glutathione (GSSG).  
Via the reducing power of its free sulfhydryl (–SH), GSH 
plays a key role in many cellular processes. For example, 
Pan and Berk’s research group [3] has shown that glutathio- 
nylation regulates TNF-α-induced capase-3 cleavage and 
apoptosis, and that capase-3 glutathionylation attenuates 
caspase-3 cleavage and inhibits endothelial cell death. This 
research group also showed that protein glutathionylation 
can regulate the cell death pathway [3]. Because GSH can 
also detoxify metal irons and ROS, it can participate in pro-
tein and DNA synthesis, and affect cell proliferation. In the 
following review, we will describe the characteristics, func-
tions and future prospects for GSH.  
1  Structure and formation of GSH 
GSH is the most abundant low molecular weight intracellu-
lar thiol and is synthesized in most biological organisms. 
GSH is synthesized from its constituent amino acids by the 
consecutive action of two enzymes: γ-glutamyl cysteine 
ligase (γ-GCL) and glutathione synthase (GS). The synthesis 
of GSH occurs intracellularly via a two-stage reaction, with 
both stages consuming ATP. During γ-GCL catalysis, the 
precursor amino acids cysteine and glutamate are combined 
to form a dipeptide, in a rate-limiting reaction. Next, the  
3058 Zhao H M, et al.   Chinese Sci Bull   October (2011) Vol.56 No.28-29 
dipeptide is combined with glycine to form GSH under GS 
catalysis [4]. GSH can then be recycled via the activity of two 
enzymes, γ-glutamyl transpeptidase and dipeptidase, which 
decomposes GSH into cysteine, glycine and γ-glutamate.  
GSH is present in either a reduced form (GSH) or an ox-
idized form (GSSG). The balance between GSH and GSSG 
is associated with the activity of two enzymes: glutathione 
reductase (GR) and glutathione peroxidase (GPx). During 
oxidative stress, GSH is oxidized via GPx to form GSSG to 
alleviate oxidative stress. Conversely, GSSG is reduced to 
GSH by GR to alleviate reduced stress. Clearly, the balance 
between GSSG and GSH is important to protect the physio-
logical functions of cells. Figure 1 shows a schematic of 
GSH recycling and the oxidation/reduction pathways. 
Besides the essential enzymes and amino acids, there are 
many factors that regulate GSH synthesis. The activity of 
GCL determines the rate of GSH synthesis and ultimately 
affects GSH synthesis. GCL comprises two subunits, a cat-
alytic subunit (GCLC) and a modifier subunit (GCLM). 
Several factors regulate GCLC activity including NF-E2 
related factor 2 (Nrf2), transforming growth factor-β1 
(TGF-β1) and hepatocyte growth factor (HGF). Upon 
recognition of the signals imparted by oxidized stress, Nrf2 
is released from keap1, escapes from proteosomal degrada-
tion, and translocates to the nucleus to induce GCL gene 
expression [5]. Interestingly, Nrf1/Nrf2-knockout mice have 
lower GCLC expression than wild-type mice [6,7]. TGF-β1 
is a pleiotropic cytokine elevated in many chronic inflam-
matory disorders that can inhibit GCLC expression and 
negatively regulate GSH synthesis [8]. HGF is a mitogen 
that induces the expression of both GCL subunits, although 
the low density unit induced the expression of GCLC only 
and increased GSH levels in subconfluent cells but not in 
confluent cells [9].  
In addition to the above findings, stabilization of GCLC 
mRNA and phosphorylation of GCLC by protein kinase A, 
protein kinase C and Ca2+-calmodulin kinase II are known 
to regulate GSH synthesis [10]. Another post-translational 
regulatory pathway of GCLC involves a direct target for 
caspase 3-mediated cleavage that occurs at Asp499 in the 
sequence AVVD499G, a target involved in some forms of 
apoptotic cell death. In turn, cleaved GCLC decreases GSH 
synthesis [11]. AP-1 and activation of NF-κB by TNF-α are 
also involved in the regulation of GSH [12]. Meanwhile, 
many physiological and biochemical studies in mammalian 
tissues and micro-organisms have shown that GSH can reg-
ulate its own formation by acting on the γ-GCL. In brief, 
many regulators participate in GSH synthesis. 
Considering the number of GSH transferases expressed 
in cells, GSH can conjugate to a large number of endoge-
nous compounds to perform its physiologic and metabolic 
functions. These targets of GSH include 1-chloro-2,4-  
dinitrobenzene; benzo(a)pyrene-4-5-oxide; cholesterol-5α, 
6α-oxide; benzo(a)pyrene-7,8-diol-9,10-oxide and aflatoxin 
B1 [13], as well as reactive oxygen species (ROS), toxic 





Figure 1  (a) GSH synthesis and recycling in cells; (b) the conversion of GSH and GSSG. 
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2  Function of GSH in cells 
2.1  GSH is an antioxidant that protects against radical 
damage 
The level of GSH is a major indicator of oxidative stress. 
ROS, such as H2O2, OH·, ONOO· and O2·, are the main 
radicals that cause cellular damage by oxidation of cell 
membrane lipids and cytosolic proteins, which ultimately 
affects cell signaling. Reduced GSH is the main ROS scav-
enger that protects cells from oxidative damage by the anti-
oxidant activity of its free thiol residue.  
The cysteine thiol residues of proteins are exceptionally 
useful in terms of structural and regulatory aspects, but are 
also exceptionally vulnerable to oxidation. Conserved cys-
teines are highly important for the function of metabolic 
enzymes and for signaling processes underlying the re-
sponses to environmental factors. If the cysteines are oxi-
dized by ROS, their structural, catalytic and/or regulatory 
functions may be affected [14]. GSH can directly detoxify 
ROS via a reaction catalyzed by GPx and hence protect the 
cysteine residues. 
2.2  GSH can detoxify cytotoxic molecules 
Although GSH is one of the most important antioxidants in 
mammalian cells, it also plays a key role in the detoxifica-
tion of electrophilic compounds, including ROS free radi-
cals, toxic metals (e.g., selenium, zinc, chromium, mercury, 
cadmium, arsenic, silver and lead) [15] and microbe effector 
proteins. These toxic materials can induce many diseases. 
As a scavenger, GSH can detoxify these cytotoxic mole-
cules through its thiol group. Of note, GSH contain six pos-
sible metal binding sites [15], and can bind to the metals to 
stabilize them in a non-reactive form or to form different 
species by redox reactions. Accordingly, GSH decreases the 
toxicity of metals. 
Through the Michael addition reaction or disulfide for-
mation, the GSH thiol decreases the effects of toxic com-
pounds or proteins. For example, ROS can easily oxidize 
lipids to generate large quantities of highly reactive α,β- 
unsaturated aldehydes (enals). At low concentrations, enals 
such as 4-hydroxy trans-2-nonenal can affect cell signal 
transduction while high concentrations of enals are cytotox-
ic. The GSH thiol can adduct the unsaturated bond of the 
enals to reduce the cytotoxic effects [16]. Thus, the conju-
gation of reactive drug metabolites to GSH is considered to 
be an important detoxification mechanism, GSH can also 
decrease xenobiotic toxicity in erythrocytes in this manner 
[17], while the toxicity of polycyclic aromatic hydrocarbons, 
a known carcinogen, can also be reduced by GSH-mediated 
detoxification as GSH can adduct the bay- and fjord-region 
diol epoxides for detoxification [17–19]. The aflatoxin 
B(1)-8,9-epoxide is a hepatocarcinogenic intermediate of 
aflatoxin B(1) that can be detoxified through GSH conjuga-
tion catalyzed by GSTA3 [20]. Finally, heterocyclic amines 
derived from food, particularly 2-amino-1-methyl-6-  
phenylimidazo[4,5-b]pyridine (PhIP), are involved in the 
etiology of human colorectal cancer as N-oxidized PhIP 
react with DNA. Notably, the toxicity of N-acetoxy-PhIP 
can be decreased by conjugation with GSH in a reaction 
catalyzed by GSTA1-1 [21]. 
2.3  Signal transduction  
It is well known that ROS function as redox messengers in 
intracellular signal transduction and regulation and that 
GSH is the main scavenger of ROS. Apart from its antioxi-
dant and detoxification activities, GSH also plays important 
roles in signaling processes and in the crosstalk of the redox 
signal with other signaling pathways. GSH regulates signal 
transduction pathways, while some signal transducers regu-
late the GSH level. We will discuss the activities of GSH in 
terms of the regulation of signal transduction below. 
(i) NF-κB pathway.  NF-κB is best known for its roles 
in immune homeostasis and inflammation, while it has an-
other important role in the regulation of the redox signaling 
pathway and is regulated by GSH. Meng et al. [22] reported 
that constitutive NF-κB activity in cancer cells can enhance 
GSH synthesis, while inhibition of NF-κB activity decreases 
GSH levels. Loss of the IKK-β signal significantly reduced 
basal NF-κB activity and decreased the binding of NF-κB to 
the promoters of GCLC and GCLM, reducing the expres-
sion of both subunits. Thus, because GCLC and GCLM 
expression is directly related to GSH biosynthesis, NF-κB 
indirectly affects GSH synthesis [23]. 
Recently, we have found some data to indicate that GSH 
or glutathionylation of proteins by GSH can also affect 
NF-κB activity. For example, glutathionylation of p65 may 
be responsible for cinnamaldehyde-mediated NF-κB inacti-
vation [24] while redox regulation by glutaredoxin in retinal 
glial cells is disturbed by hyperglycemia, leading to NF-κB 
activation and a pro-inflammatory response [25]. 
(ii) Death pathway.  Recent studies have suggested that 
GSH depletion and post-translational modification of pro-
teins through glutathionylation are related to cell death. 
GSH is crucial to counteract oxidative stress-induced liver 
injury as it detoxifies some hepatotoxins and inhibits cell 
damage induced by hepatotoxins (e.g., Flavokawain B, 
pyrrolizidine alkaloid, aflatoxin B1 and ethanol) [26–28]. In 
addition to hepatotoxins, GSH is recognized by compounds 
such as gallic acid, which is widely distributed in plants and 
foods, and can induce Hela cell death in relation to the ROS 
and GSH level [29]. Depletion of mitochondrial GSH in the 
human B lymphoma cell line by treatment with L-buthi- 
onine sulfoximine induced caspase-3 cleavage and apopto-
sis [30] indicating that GSH may be a potent early activator 
of the apoptotic signal. 
(iii) Cytokine synthesis.  The glutathione-redox balance, 
represented by the ratio of GSH to GSSG, is an important 
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regulator of cellular immune responses by participating in 
cytokine synthesis. Intestinal subepithelial myofibroblasts 
from Crohn’s disease patients exhibited an increased oxida-
tive state because of a decrease in the GSH/GSSG ratio, 
which was related to an increase in IL-6 production [31]. 
The change in the glutathione-redox balance in macrophag-
es by the activity of GSH donors (e.g., reduced glutathione 
ethyl ester or N-acetyl-L-cysteine) can differentially regu-
late the production of IL-12. At low concentrations, 
N-acetyl-L-cysteine increased IL-12 p40/p70 production. In 
contrast, at high concentrations, N-acetyl-L-cysteine re-
duced IL-12 production because of increased calmodulin 
expression [32]. 
2.4  Metabolism  
GSH can protect lipids, protein and small molecules from 
oxidized damage and may play a vital role in metabolism. 
Unfortunately, the precise role of GSH in metabolism is still 
unknown as studies have only reported the effects of GSH 
changes on metabolic imbalances. For example, a decrease 
in GSH accelerates adipogenesis in pre-adipocytes [33]. 
Meanwhile, oxidative stress is related to several metabolic 
abnormalities observed in obesity [34]. Glyoxalase 1 (Glo1) 
and glyoxalase 2 (Glo2) are enzymes that catalyze the con-
version of toxic a-oxo-aldehydes into the corresponding 
a-hydroxyl acids using L-GSH as a cofactor and glutathi-
onylation of Glo1 on cysteine 139 is an important post- 
translational modification, which strongly inhibits enzyme 
activity. Thus, inhibition of Glo1 is expected to be an im-
portant factor within the context of redox-dependent regula-
tion of glucose metabolism in cells [35].  
Learning from the metabolic phenomena associated with 
varying levels of GSH, we speculate that GSH may be in-
volved in many components of metabolism by glutathi-
onylation of crucial metabolism enzymes or formation of 
disulfide bridges to the change redox balance and hence 
affect metabolism.  
2.5  Cell cycle 
GSH is abundant in cells and is found in most cellular 
compartments, including the nucleus. GSH plays a pivotal 
role in cell proliferation by its transport between the differ-
ent intracellular compartments. Analyses by many re-
searchers have concluded that GSH affect the cell cycle 
through different mechanisms. Some researchers have 
found that GSH co-localizes with nuclear DNA at the early 
stage of proliferation in plant and animal cells [36]. During 
the G1 and S phases of the cell cycle, GSH aggregation and 
sequestration in the nucleus has a marked effect on cellular 
redox homoeostasis and gene expression. When GSH is 
sequestered in the nucleus, the levels of transcripts encoding 
stress and defense proteins are decreased. It can also regu-
late the activity of telomerase in vivo, an enzyme that is 
coordinated with changes in the critical cell cycle proteins, 
particularly id2 and E2F4 [37]. Other than its effects on 
gene expression by regulating histones and PARP, GSH can 
also enable the cell to retain memory of the cellular redox 
environment [38]. 
Overall, GSH participates in many biochemical reactions 
in cells and maintains the redox balance to maintain normal 
cellular activity. We have summarized the intracellular roles 
of GSH in Figure 2.  
3  GSH-related diseases 
Because GSH plays a central role in regulating the redox 
pathway, changes in the level of GSH can induce some 
changes in physiologic indicators and may potentially in-
duce certain diseases. For example, recent studies have 
shown that elderly people with hypertension have higher 
GSH concentrations, higher activities of GSH transferase 
and GSH reductase in erythrocytes, but no difference in 
GSH peroxidase activity, indicating that GSH play some 
role in the regulation of blood pressure [39]. Chon et al. [40] 
used GSH-depleted mice to show that differential expres-
sion of GSH affects energy and protein metabolism in rela-
tion to the pathogenetic background of hypertension. Staroń 
et al. [41] found that rheumatoid arthritis (RA) patients have 
higher ROS levels than healthy people, whereas the expres-
sion of the antioxidant enzymes catalase and GPx were not 
significant different, and that superoxide dismutase antioxi-
dant activity and –SH levels were lower in RA patients than 
in the control group. The GSH:GSSG ratio was significantly 
(P < 0.05) decreased in the plasma and lymphocyte cells of 
patients with Ménière’s disease [42]. 
Many neurodegenerative disorders, including amyo-
trophic lateral sclerosis, Alzheimer’s disease, and Parkin-
son’s disease, are associated with oxidative stress and the 
failure of antioxidant systems, particularly a decrease in 
GSH content [43,44].  
Infection diseases are also associated with concomitant 
changes in GSH levels. For example, patients with Helico-
bacter pylori-infected gastric epithelial cells had signifi-
cantly lower concentrations of GSH than normal controls, 
and that the reduced GSH levels following H. pylori colo-
nization of the gastric mucosa may be caused by a direct 
effect of the bacterium and by associated inflammatory re-
sponses [45]. Pyocyanin extracted from Pseudomonas ae-
ruginosa bacteria affect human bronchial epithelial (HBE) 
cells in the following way: mitochondrial GSSG is in-
creased, oxidant-sensitive proteins (HIF-1α and HO-1) are 
increased, and GSH is decreased. Changes in thiol levels as 
well as oxidant-sensitive proteins may contribute to P. ae-
ruginosa-mediated lung injury [46]. As infection with H. 
pylori and P. aeruginosa reduce the host’s GSH levels, 
GSH may offer an attractive therapy target in the future. In 
fact, some researchers have been trying to target GSH to  
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Figure 2  Intracellular roles of GSH. In the mitochondrion, GSH can regulate succinyl-CoA transferase and ATP synthase to maintain energy metabolism. 
In the nucleus, GSH regulates the cell cycle by co-localizing with DNA to regulate nuclear protein expression. In the cytosol, GSH has many roles, including 
antioxidant defense, detoxification, protein synthesis and modification and maintain the redox balance. In addition, GSH also participates in many metabolic 
processing of many biological materials. 
protect against infection. For example, L-cysteine can in-
crease GSH synthesis and the subsequent increases in GSH 
levels can enhance the defense against influenza virus in-
fection [47]. 
We have learned from these findings that a decrease in 
GSH can lead to many diseases, benefit pathogen infection 
and have adverse effects on the host. Therefore maintaining 
the GSH balance in cells is very important and necessary to 
maintain the health of cells and organisms. 
4  Concluding remarks and future perspectives 
for GSH research 
GSH takes part in many biochemical reactions in cells 
through its thiol group by forming adducts with unsaturated 
bonds or forming disulfide bonds with proteins containing 
cysteine. Although many studies of GSH and glutathionyla-
tion have been conducted, they have consistently described 
phenomena, while the mechanisms involved in the activity 
of GSH and glutathionylation remain largely unknown.  
Many diseases and some pathogen infections affect GSH 
levels. Most pathogens increase ROS levels and decrease 
GSH levels. Therefore, some researchers have used ROS or 
GSH as therapeutic targets. Antioxidants such as N-acetyl- 
cysteine, S-acetyl glutathione and S-acetyl-beta-mercap- 
toethylamine can replenish the depleted GSH levels during 
infection and inhibit pathogen invasion. Furthermore, these 
small molecules are considered to be pro-drugs that can 
inhibit complications of HIV [48]. Although we know that 
infection with many pathogens can affect GSH levels, the 
mechanisms responsible for changes in GSH levels and how 
the changes in GSH levels affect the cell response are un-
clear.  
In conclusion, GSH plays many extremely important 
roles in maintaining the health of cells, and may offer a 
therapeutic target for some diseases. Therefore, we believe 
it is important to further explore the functions of GSH. Alt-
hough much research has been published on GSH, these 
studies have mainly described the phenomena and specu-
lated on mechanisms; the real function and mechanism of 
GSH remain unknown, and we must endeavor to do our best 
to solve this mystery. 
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